Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Singapore A global-Asia pharmaceutical hub
Lee Eng Keat, International Director (Asia Pacific) of the Singapore Economic Development Board (EDB), speaks about the synergy…
Discover the hidden OTC Gems of the Indian pharma market
Sreedevi Yallamrazu, Sr Strategic Analyst, CubeX, a division of Sorento Healthcare Communications, says that new business models…
Leveraging social media for success
B Sriram, Executive Director– Healthcare, Direxions Marketing Solutions, advises Indian pharma to deploy social media for…
Patents – why and when?
Milind Sathe, Deputy General Manager – Projects, Unichem Laboratories gives a rundown on patents, its uses, objectives,…
GOM’s proposed simple average pricing to result in sharper price cuts
AIOCD-PharmaTrac data also shows some companeis will have a lower impact under SAP
‘Criteria of speaker selection is important to convey the quality level’
Dr Srinubabu Gedela, Director, OMICS Group of Conferences, reveals more to Sachin Jagdale about pharma conferences and their plans…
Pharmexcil expects Ministry notification on branding for drug exports within a week
Notification to clarify status and expected to bring relief to pharma exporters
Glenmark Generics announces settlement of Paragraph IV litigation with Janssen Pharmaceuticals
Glenmark will launch a generic version of Ortho Tri-cyclen Lo tablets as early as December 31, 2015
CDSCO drafts guidelines on recall and rapid alert system for drugs
The guidelines are biologics and vaccines as well and the targets would be enforced in the next three to four months
Novartis to construct biotechnology facility in Singapore with an investment of over $500 million
Construction of new production facility to start in early 2013 and is expected to be fully operational by the end of 2016